Relapsed and refractory malignant rhabdoid tumors – Evaluation of new therapeutic approaches
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Augsburg, Universität Augsburg, Dissertation, 2024
- Keyword
-
Krebs
Therapie
Tumor
Kind
Krebs
Tumorregister
Therapieerfolg
Evaluation
Kind
Säugling
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2025
- Creator
- Contributor
-
Frühwald, Michael C.
- URN
-
urn:nbn:de:bvb:384-opus4-1179895
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Steinbügl, Mona Juliane
- Frühwald, Michael C.
- Universität Augsburg
Time of origin
- 2025
Other Objects (12)
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Apoptotic response of malignant rhabdoid tumor cells
Malignant extrarenal rhabdoid tumor: a case report
Fetal-onset malignant rhabdoid tumor: a case report
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
Prenatal Diagnosis of Renal Rhabdoid Tumor: A Rare Malignant Neoplasm
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Apoptotic response of malignant rhabdoid tumor cells
Malignant extrarenal rhabdoid tumor: a case report
Fetal-onset malignant rhabdoid tumor: a case report
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
Prenatal Diagnosis of Renal Rhabdoid Tumor: A Rare Malignant Neoplasm
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors
Current and emerging therapeutic approaches for extracranial malignant rhabdoid tumors
An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
Apoptotic response of malignant rhabdoid tumor cells
Malignant extrarenal rhabdoid tumor: a case report
Fetal-onset malignant rhabdoid tumor: a case report
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
Dissecting genetic pathways in schwannomatosis and malignant rhabdoid tumour
Prenatal Diagnosis of Renal Rhabdoid Tumor: A Rare Malignant Neoplasm
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia